Inventor · disambiguated record
Rodney Lawrence Parsons, Jr.
Also filed as: PARSONS JR RODNEY LAWRENCE · PARSONS RODNEY L · PARSONS RODNEY LAWRENCE
7 granted patents·2 pending applications·123 citations·filing 1997–2020
84Inventor score
Top patents by PatentIndex Score
9 records- 0194US5874430A4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·87 cites·22 claims
- 0273US6028237ASynthesis of cyclopropylacetyleneDU PONT PHARM CO·Filed 1997·Granted Feb 22, 2000·15 cites·19 claims
- 0363US6140499A4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1998·Granted Oct 31, 2000·7 cites·7 claims
- 0453US2023075422A1Use of fucosylation inhibitor for producing afucosylated antibodyBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 0551US6225317B1Crystalline (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinoneDU PONT PHARM CO·Filed 1999·Granted May 1, 2001·5 cites·24 claims
- 0649US5932726AAsymmetric synthesis of benzoxazinonesDU PONT PHARM CO·Filed 1997·Granted Aug 3, 1999·9 cites·42 claims
- 0747US6303780B14,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 2000·Granted Oct 16, 2001·0 cites·9 claims
- 0841US6555686B2Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2001·Granted Apr 29, 2003·0 cites·44 claims
- 0933US2001044540A1Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rodney Lawrence Parsons, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →